Gujarat Inject loses Chairman, CFO & Whole-Time Director in single death
Deepak Diwan Bachwani died just weeks after taking charge following the MD's exit. The nano-cap's solar pivot now faces immediate execution risk.
— 4 earlier stories on Gujarat Inject (Kerala) Ltd. →What's new
- Deepak Diwan Bachwani, Chairman, CFO and Whole-Time Director, died on 23 June 2026.
- He was appointed only weeks earlier after the MD resigned, centralising top strategy and finance.
- Nano-cap had just pivoted to solar with ₹14.49 cr and ₹1.07 cr orders and a 7x revenue surge.
Why this matters
The loss of an executive who simultaneously held three critical leadership roles creates an immediate governance vacuum for a company with a ₹171 cr market cap. Bachwani was the architect of the solar pivot that drove a 7x revenue jump in Q4. Finding replacements quickly is now the pressing risk; delays could derail the order book.
What we're watching
- Whether the board can appoint a new Chairman and CFO within weeks.
- Impact on the two recently won solar orders (₹14.49 cr and ₹1.07 cr).
- Any further resignations or governance disclosures from the micro-cap.
The full read
Gujarat Inject (Kerala) has lost its Chairman, Whole-Time Director and Chief Financial Officer — all three roles held by the same person. Deepak Diwan Bachwani died on 23 June 2026, just weeks after he was appointed to replace the resigning managing director. He was the driving force behind the solar pivot that delivered a 7x revenue jump in Q4 and two recent orders worth ₹14.49 crore and ₹1.07 crore. For a nano-cap with a ₹171 crore market cap, the loss of an executive who simultaneously ran strategy and finance is a severe blow. The board now faces an immediate test: fill these roles fast or risk stalling momentum. The stock is likely to reflect this uncertainty.
Questions answered
- What roles did Deepak Diwan Bachwani hold?
- He was Chairman, Chief Financial Officer, and Whole-Time Director of Gujarat Inject (Kerala) Ltd.
- Why is this death particularly disruptive?
- He was appointed just weeks ago after the managing director quit, and he was the driving force behind the solar pivot. His absence removes the key decision-maker at a critical juncture.
- How large is Gujarat Inject (Kerala)?
- It has a market cap of ₹171 cr, Q4 revenue of ₹30.7 cr, and a net profit of ₹2 cr.
- What recent orders did the company win?
- A ₹14.49 cr solar-module order from Deon Energy and a ₹1.07 cr order from Ottire Lifestyle for 1,334 solar modules.
- What is the immediate risk for the company?
- A leadership vacuum that could delay execution on the orders and expansion plans, potentially reversing the momentum from the 7x revenue jump in Q4.
- How quickly must the board act?
- The board needs to appoint a new Chairman and CFO urgently to restore investor confidence and ensure continuity in day-to-day operations.
Gujarat Inject (Kerala) Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on GUJINJEC →- 24 Jun 2026 · 5:25 PM IST Gujarat Inject loses Chairman, CFO & Whole-Time Director in single death
- 13d ago Gujarat Inject lands ₹14.49 cr solar order, nearly 40% of annual revenue
- 16d ago Gujarat Inject wins ₹1.07 cr solar module order from Ottire Lifestyle
- 35d ago Gujarat Inject (Kerala) posts 7x revenue jump in Q4, flips to profit
- 35d ago Gujarat Inject (Kerala) Q4 revenue zooms 19x to ₹30.7 cr